Anhui Conch Cement Company Limited (HKG:0914)

Sage Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	63,949	70,229	68,382	16,158	69,559	62,300
Short-Term Investments	-	-	-	40,900	-	-
Trading Asset Securities	500.47	509.2	2,211	10,755	24,279	26,883
Cash & Short-Term Investments	64,449	70,739	70,593	67,813	93,837	89,183
Cash Growth	-5.65%	0.21%	4.10%	-27.73%	5.22%	20.79%
Accounts Receivable	12,842	11,110	12,664	16,958	14,594	10,923
Other Receivables	1,527	648.22	2,756	5,941	2,832	1,425
Receivables	14,369	12,250	15,928	23,203	17,612	12,543
Inventory	9,082	9,053	12,560	11,679	11,084	10,466
Prepaid Expenses	-	63.2	63.47	-	34.05	17.97
Other Current Assets	2,479	1,656	2,089	3,713	1,049	981.67
Total Current Assets	90,379	93,762	101,233	106,408	123,616	113,192
Property, Plant & Equipment	97,825	99,321	96,703	97,722	73,926	68,078
Long-Term Investments	9,581	20,425	9,113	10,119	9,405	4,645
Goodwill	1,452	1,452	1,147	1,146	876.04	576.04
Other Intangible Assets	35,938	34,264	32,442	24,638	18,240	13,710
Long-Term Deferred Tax Assets	1,547	1,486	1,554	1,249	758.06	851.78
Other Long-Term Assets	18,013	3,544	3,914	2,402	3,397	472.75
Total Assets	254,735	254,635	246,356	243,976	230,556	201,853
Accounts Payable	5,888	6,127	6,654	6,660	6,828	4,783
Accrued Expenses	223.18	3,060	2,876	3,004	3,477	3,381
Short-Term Debt	3,944	5,749	4,480	-	3,290	1,982
Current Portion of Long-Term Debt	1,899	1,942	2,832	12,366	4,796	1,179
Current Portion of Leases	-	30.93	35.39	24.87	21.13	17.11
Current Income Taxes Payable	2,419	887.59	934.18	770.63	3,566	3,962
Current Unearned Revenue	2,809	2,569	2,890	3,565	3,254	4,245
Other Current Liabilities	8,776	8,527	9,073	9,182	7,444	4,758
Total Current Liabilities	25,958	28,892	29,774	35,571	32,677	24,306
Long-Term Debt	23,062	22,281	15,876	10,000	4,104	7,193
Long-Term Leases	233.92	240.36	198.02	56.05	49.65	36.63
Long-Term Unearned Revenue	1,093	1,055	870.47	748.7	595.93	532.44
Long-Term Deferred Tax Liabilities	1,694	1,703	1,616	1,692	1,272	771.57
Other Long-Term Liabilities	85.4	86.12	-	-	-	397.44
Total Liabilities	52,127	54,258	48,335	48,068	38,699	33,237
Common Stock	5,299	5,299	5,299	5,299	5,299	5,299
Additional Paid-In Capital	10,651	10,619	10,721	9,907	10,515	10,882
Retained Earnings	176,144	174,295	171,654	169,407	167,971	145,969
Treasury Stock	-500.59	-500.59	-339.16	-	-	-
Comprehensive Income & Other	-1,389	-1,772	-1,946	-1,051	-75.62	19.23
Total Common Equity	190,205	187,940	185,389	183,563	183,709	162,169
Minority Interest	12,402	12,437	12,632	12,346	8,148	6,446
Shareholders' Equity	202,608	200,377	198,021	195,909	191,857	168,616
Total Liabilities & Equity	254,735	254,635	246,356	243,976	230,556	201,853
Total Debt	29,139	30,243	23,421	22,446	12,261	10,408
Net Cash (Debt)	35,310	40,495	47,172	45,367	81,576	78,775
Net Cash Growth	-20.47%	-14.15%	3.98%	-44.39%	3.56%	26.06%
Net Cash Per Share	6.70	7.67	8.90	8.56	15.39	14.87
Filing Date Shares Outstanding	5,277	5,277	5,284	5,299	5,299	5,299
Total Common Shares Outstanding	5,277	5,277	5,284	5,299	5,299	5,299
Working Capital	64,421	64,870	71,458	70,836	90,939	88,886
Book Value Per Share	36.04	35.61	35.08	34.64	34.67	30.60
Tangible Book Value	152,815	152,225	151,800	157,779	164,593	147,883
Tangible Book Value Per Share	28.96	28.85	28.73	29.77	31.06	27.91
Land	-	66,842	62,612	58,824	50,336	47,180
Machinery	-	89,479	84,381	79,723	67,891	63,667
Construction In Progress	-	9,356	10,840	8,475	7,273	4,711

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.